-
- Astrid C. Haugen
- 1Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina;
-
- Ajay Goel
- 2Gastrointestinal Cancer Research Laboratory, Baylor Research Institute and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas; Departments of
-
- Kanae Yamada
- 3Molecular Biology,
-
- Giancarlo Marra
- 6Institute for Molecular Cancer Research, University of Zurich, Zurich, Switzerland; and
-
- Thuy-Phuong Nguyen
- 2Gastrointestinal Cancer Research Laboratory, Baylor Research Institute and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas; Departments of
-
- Takeshi Nagasaka
- 2Gastrointestinal Cancer Research Laboratory, Baylor Research Institute and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas; Departments of
-
- Shinsaku Kanazawa
- 4Surgery, and
-
- Junichi Koike
- 4Surgery, and
-
- Yoshinori Kikuchi
- 3Molecular Biology,
-
- Xiaoling Zhong
- 3Molecular Biology,
-
- Michitsune Arita
- 3Molecular Biology,
-
- Kazutoshi Shibuya
- 5Surgical Pathology, Faculty of Medicine, Toho University, Ohta-ku, Tokyo, Japan;
-
- Mitsuo Oshimura
- 7Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, Yonago, Tottori, Japan
-
- Hiromichi Hemmi
- 3Molecular Biology,
-
- C. Richard Boland
- 2Gastrointestinal Cancer Research Laboratory, Baylor Research Institute and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas; Departments of
-
- Minoru Koi
- 2Gastrointestinal Cancer Research Laboratory, Baylor Research Institute and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas; Departments of
説明
<jats:title>Abstract</jats:title> <jats:p>Microsatellite instability (MSI) is a hallmark of mismatch repair (MMR) deficiency. High levels of MSI at mononucleotide and dinucleotide repeats in colorectal cancer (CRC) are attributed to inactivation of the MMR genes, hMLH1 and hMSH2. CRC with low levels of MSI (MSI-L) exists; however, its molecular basis is unclear. There is another type of MSI—elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)—where loci containing [AAAG]n or [ATAG]n repeats are unstable. EMAST is frequent in non-CRCs; however, the incidence of EMAST and its cause in CRC is not known. Here, we report that MutS homologue 3 (MSH3) knockdown or MSH3-deficient cells exhibit the EMAST phenotype and low levels of mutations at dinucleotide repeats. About 60% of 117 sporadic CRC cases exhibit EMAST. All of the cases defined as MSI-H (16 cases) exhibited high levels of EMAST. Among 101 non–MSI-H cases, all 19 cases of MSI-L and 35 of 82 cases of MSS exhibited EMAST. Although non–MSI-H CRC tissues contained MSH3-negative tumor cells ranging from 2% to 50% of the total tumor cell population, the tissues exhibiting EMAST contained more MSH3-negative cells (average, 31.5%) than did the tissues not exhibiting EMAST (8.4%). Taken together, our results support the concept that MSH3 deficiency causes EMAST or EMAST with low levels of MSI at loci with dinucleotide repeats in CRC. [Cancer Res 2008;68(20):8465–72]</jats:p>
収録刊行物
-
- Cancer Research
-
Cancer Research 68 (20), 8465-8472, 2008-10-15
American Association for Cancer Research (AACR)
